Author(s): Deepak Bhattacharya, Kavita Chenania, Asadollah Asadi, Chandra Sekhar Tripathy, U. S. Mahadeva Rao, Diba Kiani

Email(s): raousm@unisza.edu.my

DOI: 10.52711/0974-360X.2025.00139   

Address: Deepak Bhattacharya1, Kavita Chenania2, Asadollah Asadi3, Chandra Sekhar Tripathy4, U. S. Mahadeva Rao5*, Diba Kiani6
1Policy, Critical Nursing, Drug Discovery
Medicinal Toxicology & QC, At : Sri Radha Krishna Raas Mandir, Kedar Gouri Main Road, Bhubaneswar–751002, Odisha, India 2Professor, Department of Obstetrics and Gynaecology, IMS and SUM Hospital, 3Associate professor, Department of Biology, University of Mohaghegh, Ardabili, Iran 4Department of Botany, Centurion University of Technology and Management, Bhubaneswar, Odisha, India, 5School of Basic Medical Sciences,Faculty of Medicine, Kampus Perubatan, Universiti Sultan Zainal Abidin, 20400 Kuala Terengganu , Malaysia. 6Microbiologist, Islamic Azad University, Tabriz branch, Iran *Corresponding Author

Published In:   Volume - 18,      Issue - 2,     Year - 2025


ABSTRACT:
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide, with rising incidence and significant challenges, including high recurrence rates, local and distant metastasis, and severe lifestyle disruptions. Despite the availability of treatment options, including chemotherapy, the need for cold-chain-dependent drugs, and the associated toxic side effects pose substantial barriers to effective care, particularly in rural and remote areas. Family Physicians (FPs), who are well-equipped with local support teams, medical expertise, and drug storage facilities, are uniquely positioned to assist in CRC management. However, due to a widespread misconception that legal frameworks do not permit their involvement, they largely refrain from treating cancer patients. Notably, in India—the world’s largest democracy—laws do allow FPs to play a more active role in oncology care, yet this remains largely unknown and underutilized. FPs also possess deep knowledge of Functional Foods (FFs), which are abundant in tropical and equatorial regions and have demonstrated potential in mitigating chemotherapy side effects, enhancing patient recovery, and improving overall well-being. Integrating FFs into CRC management under the supervision of FPs could offer a holistic, patient-centered approach that benefits all stakeholders—patients, healthcare providers, and the pharmaceutical industry. This paper explores the potential role of FPs in CRC care, the integration of FFs in treatment regimens, and the medico-legal considerations surrounding this paradigm shift. By leveraging the expertise and accessibility of FPs, CRC management can be made more comprehensive, ensuring better patient outcomes, economic benefits, and an expanded healthcare market that prioritizes family welfare and prolonged survival.


Cite this article:
Deepak Bhattacharya, Kavita Chenania, Asadollah Asadi, Chandra Sekhar Tripathy, U. S. Mahadeva Rao, Diba Kiani. Bridging the Gap: The Role of Family Physicians in Colorectal Cancer Care and Functional Food Integration. Research Journal of Pharmacy and Technology. 2025;18(2):949-4. doi: 10.52711/0974-360X.2025.00139

Cite(Electronic):
Deepak Bhattacharya, Kavita Chenania, Asadollah Asadi, Chandra Sekhar Tripathy, U. S. Mahadeva Rao, Diba Kiani. Bridging the Gap: The Role of Family Physicians in Colorectal Cancer Care and Functional Food Integration. Research Journal of Pharmacy and Technology. 2025;18(2):949-4. doi: 10.52711/0974-360X.2025.00139   Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-71


REFERENCES:
1.    Roehr B. American Psychiatric Association Explains DSM-5. Bmj. 2013 Jun 6; 346.
2.    Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen HU. Anxiety Disorders. Nature Reviews. Disease Primers. 2017 May 4; 3:17024.
3.    Szmaglinska M, Andrew L, Massey D, Kirk D. Exploring the Underutilized Potential of Clinical Hypnosis: A Scoping Review of Healthcare Professionals’ Perceptions, Knowledge, and Attitudes. International Journal of Clinical and Experimental Hypnosis. 2024 Apr 2; 72(2):109-38.
4.    Fedoce AD, Ferreira F, Bota RG, Bonet-Costa V, Sun PY, Davies KJ. The role of oxidative stress in anxiety disorder: cause or consequence?. Free Radical Research. 2018 Jul 3; 52(7):737-50.
5.    Reid DB. Hypnosis and anxiety.
6.    Milling LS. Evidence-based practice in clinical hypnosis. American Psychological Association; 2023.
7.    Hammond, D. C. (2018). Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Review of Neurotherapeutics, 18(2), 89-97.
8.    Valentine, K. E., Milling, L. S., Clark, L. J., and Moriarty, C. L. (2019). The efficacy of hypnosis as a treatment for anxiety: A meta-analysis. International Journal of Clinical and Experimental Hypnosis, 67(3), 336-363.
9.    Oakley, D. A., and Halligan, P. W. (2017). Hypnotic suggestion and cognitive neuroscience. Trends in Cognitive Sciences, 21(8), 589-599.
10.    Rothe A, Rich AS, Li ZW. Topics and trends in cognitive science (2000-2017). InProceedings of the Annual Meeting of the Cognitive Science Society. 2018 (Vol. 40).
11.    Motallebi A, Fathi M, Mazhari F, Hoseinzadeh M, Parisay I. Hypnosis and nitrous oxide impact on the school aged patients’ anxiety and cooperation candidate for tooth extraction: A Randomized Clinical Trial. Heliyon. 2024 Aug 15; 10(15).
12.    Tezcan B, Ademoğlu D, Can M, Kazancı D, Mungan I, Taştemur S, Ceylan C, Turan S. A randomized clinical trial on the effect of hypnosis on anxiety and pain in rigid cystoscopy patients. Journal of Endourology. 2021 Jan 1; 35(1):47-53.
13.    Wolf TG, Schläppi S, Benz CI, Campus G. Efficacy of hypnosis on dental anxiety and Phobia: A systematic review and meta-analysis. Brain Sciences. 2022 Apr 20; 12(5):521.
14.    Anjomshoaa H, Snagui Moharer R, Shirazi M. Comparing the effectiveness of training cognitive behavioral therapy and neuro-linguistic programming strategies on enhancing resilience of high school students in Kerman, Iran. International Journal of Pediatrics. 2020 Aug 1; 8(8):11877-89.
15.    Ahmadi Malayeri, G., Rahmani, M. A., and Pourasghar Arabi, M. (2023). The effectiveness of cognitive-behavioral hypnotherapy on distress tolerance and aggression in women with premenstrual dysphoria. AFTJ,4(1): 157-171
16.    Daitch C. Cognitive behavioral therapy, mindfulness, and hypnosis as treatment methods for generalized anxiety disorder. American Journal of Clinical Hypnosis. 2018 Jul 9; 61(1):57-69.
17.    Tukaev R. The integrative theory of hypnosis in the light of clinical hypnotherapy. Hypnotherapy and Hypnosis. London: Intech Open. 2020 Jun 11:41-72.
18.    American Psychological Association. 2024 work in America survey: psychological safety in the changing workplace.
19.    Schoenberger NE. Cognitive-Behavioral Hypnotherapy for Phobic Anxiety.
20.    Halsband, U., and Gerhard Wolf, T. Functional Changes in Brain Activity After Hypnosis: Neurobiological Mechanisms and Application to Patients with a Specific Phobia—Limitations and Future Directions. International Journal of Clinical and Experimental Hypnosis. 2019; 67(4): 449–474.
21.    Volkovyskaya E. The use of clinical hypnotherapy in the treatment of social anxiety and panic attacks: a case study. Contemporary Hypnosis and Integrative Therapy. 2020 Mar 1; 34(1).
22.    Pournesaei GS, Pooragha Rodbardeh F, Rabiei F. The Effectiveness of Cognitive Hypnotherapy in Reducing the Anxiety of Women with Generalized Anxiety Disorder. Journal of Modern Psychology. 2023 Jan 1; 3(1):50-60.
23.    Fuhr K, Bender A, Wiegand A, Janouch P, Drujan M, Cyrny B, Schweizer C, Kreifelts B, Nieratschker V, Batra A. Hypnotherapy for agoraphobia—Feasibility and efficacy investigated in a pilot study. Frontiers in Psychology. 2023 Aug 10; 14:1213792.
24.    Zhang H, Yuan X, Mohd Zain NB, Gao Y. Analysis of therapeutic effect of subliminal cognition combined with hypnotherapy on anxiety disorder via neural network. Biotechnology and Genetic Engineering Reviews. 2024 Nov 1; 40(4):3856-73.
25.    Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychological Medicine. 2008 Mar; 38(3):365-74.
26.    Churchill R, Moore TH, Furukawa TA, et al. ‘Third waveand#39; cognitive and behavioural therapies versus treatment as usual for depression. The Cochrane Library 2013; 10:1–47.
27.    Young JE, Mattila DE. Schema-focused therapy for depression. In: Reinecke MA, Davison MR, eds. Depression: A Practitionerand#39;s Guide to Comparative Treatments, New York: Springer. 2007: 9: 291–313.
28.    Greenberg LS, Watson JC. Emotion-focused therapy for depression. Washington: American Psychological Association, 2006.
29.    McCullough JP. Treatment for chronic depression: Cognitive behavioral analysis system of psychotherapy (CBASP). J Psych other Integr. 2003; 13:241–63.
30.    Teasdale JD, Segal ZV, Williams JMG, et al. Prevention of relapse/ recurrence inmajor depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000; 68:615–23.
31.    Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy model, processes, and outcomes. Behav Res Ther. 2006; 44:1–25.
32.    Menon S, Bhagat V. Making a Case for Hypnosis: Using the RE-AIM Framework to Recognize Hypnosis as a Stand-Alone Therapeutic Intervention within Healthcare and Educational Systems. Research Journal of Pharmacy and Technology. 2024 Feb 20; 17(2): 953-62.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available